These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3281242)

  • 1. [Value of the characterization of anti-ribonucleoproteins and anti-Sm antibodies by immunoblotting and immunoprecipitation in connectivitis].
    Combe B; Lussiez V; Rucheton M; Graafland H; Brunel C; Sany J
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):47-9. PubMed ID: 3281242
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characterization by immunoblotting (western blot) of anti-RNP antibodies in 36 connective tissue disease patients of whom 26 had mixed connective tissue disease. Comparison with 28 lupus patients with anti-Sm antibodies].
    Meyer O; Kuntz D; Kahn MF; Bourgeois R; Haim T
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):39-44. PubMed ID: 2727580
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
    Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-RNP antibodies and their clinical significance.
    Montecucco C
    Br J Rheumatol; 1990 Oct; 29(5):322-4. PubMed ID: 2224398
    [No Abstract]   [Full Text] [Related]  

  • 5. SLE or MCTD and the snurp in the splicing.
    Whittingham S
    J Rheumatol; 1990 Oct; 17(10):1260-2. PubMed ID: 1701487
    [No Abstract]   [Full Text] [Related]  

  • 6. [HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease].
    Balthazar PA; Gabriel Júnior A; de Oliveira DP; de Oliveira MA; Rosales T; Iglesias SS; Assad RL; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(6):249-53. PubMed ID: 3879739
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
    Lemmer JP; Curry NH; Mallory JH; Waller MV
    J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
    Cortés JJ; Mendoza F; Reyes PA
    J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
    Hauke G; Lührmann R; Metz B; Peter HH
    Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.
    Zouali M; Jefferis R; Eyquem A
    Immunology; 1984 Mar; 51(3):595-600. PubMed ID: 6230310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus.
    Kaufman RL; Kitridou RC
    J Rheumatol; 1982; 9(4):549-55. PubMed ID: 6182291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
    Benhamou CL; Amor B; Menkes CJ; Delbarre F
    Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of anti-Sm antibody in systemic lupus erythematosus & related disorders.
    Singh RR; Malaviya AN; Kailash S; Varghese T
    Indian J Med Res; 1991 Jun; 94():206-10. PubMed ID: 1834551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.